Rua Bioscience

Rua is a New Zealand cannabis pharmaceutical company that is aiming to be a leading producer of cannabinoid derived medicines. The Company was established in 2017 in part to support local economic development in the Tairawhiti (East Coast) region, and is a pioneer in the New Zealand medicinal cannabis sector. It was the first company in New Zealand to obtain a licence to cultivate cannabis for research purposes. Rua will operate in the research, cultivation, extraction and manufacturing parts of the medicinal cannabis supply chain.


Company Details

Registered Office: 1 Commerce Place, Awapuni, Gisborne 4071
Postal Address: 1 Commerce Place, Awapuni, Gisborne 4071
Telephone: +64-6-390-6938
Facsimile: n/a
Website: www.ruabio.com
First Listed: 22/10/2020
Balance Date: 30 June
AGM: 12/10/2022

Directors and Executives

Tony Barclay
Independent Director
Panapa Ehau
Executive Director
Teresa Farac-Ciprian Independent Non-Executive Director
Brett Gamble
Non-Executive Director
Paul Naske
Chief Executive Officer
Anna Stove
Chair
Hamish White
Chief Financial Officer

Announcements

Title Date Type
Record Sales in March for New Zealand Mon, Mar 31 2025 08:30 am MKTUPDTE
Rua Bioscience Half Year Results data Mon, Mar 03 2025 08:30 am GENERAL
Rua Bioscience Half Year Results - Global Growth Fri, Feb 28 2025 08:30 am HALFYR
Capital Change Notice Fri, Feb 14 2025 10:24 am SECISSUE
Revenue exceeds previous forecast Tue, Jan 28 2025 09:13 am MKTUPDTE
Revenue exceeds previous forecast Tue, Jan 28 2025 08:57 am MKTUPDTE
Psilocybin clinical trial update Tue, Jan 21 2025 01:29 pm MKTUPDTE
Capital Change Notice Mon, Jan 06 2025 12:33 pm SECISSUE
Capital Change Notice Tue, Dec 31 2024 12:24 pm OFFER
Rua Bioscience announces launch of new products in the UK Thu, Dec 19 2024 11:20 am MKTUPDTE

Major Holdings Announcements

Date Name No. Held % Current
22/12/22 Michael John Wilding 8,509,556 - 5.39
18/03/22 Hikurangi Enterprises Limited 8,132,620 - 5.43
17/03/22 Hikurangi Bioactives Limited Partne 4,000,000 12.58 2.67
22/10/20 Tailorspace Capital Limited, Tailor 11,129,375 - 7.95
22/10/20 Fang Group Investment Limited and F 23,584,939 - 16.85
22/10/20 Andrew Charles Williams 7,756,838 - 5.54

Director’s Interests Announcements

Date Name No. Held % Details Other
31/05/23 Hamish White 80,895 - - -
17/05/23 Antony George Barclay 50,000 - - -
02/11/21 Paul Naske 159,872 - - -
02/11/21 Rob Mitchell 288,251 - - -
02/11/21 Panapa Ehau 474,224 - - -
02/11/21 Trevor Burt 958,002 - - -
22/10/20 Martin Smith 2,544,732 - - -
22/10/20 Brett Gamble 1,805,914 - - -
22/10/20 Anna Stove 763,896 - - -

Analysts’ Forecasts

No forecasts available

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 06/06/2023


Markets News

Pacific Edge reviews US pricing for new Cxbladder test
Markets

Pacific Edge reviews US pricing for new Cxbladder test

Cxbladder Triage Plus is a ‘next-generation’ Cxbladder test.

Infrastructure

Second Auckland airport runway pushed out to 2038

The new draft master plan will be finalised by year-end.

Second Auckland airport runway pushed out to 2038
Finance

Kernel adds shares and ETFs, but no day trading

Kernel Wealth's test share buyers have been piling into Nvidia, Apple and Google.

Kernel adds shares and ETFs, but no day trading
Markets Market Close

NZ sharemarket up as Trump eases tariff stance

Investors heaved a sigh of relief as NZ shares responded to Trump's change of heart.

Tom Raynel 28 Apr 2025
NZ sharemarket up as Trump eases tariff stance
Primary Sector

Fonterra's plans unchanged despite court ruling

Bega reiterates its interest in Oceania business. 

Rebecca Howard 28 Apr 2025
Fonterra's plans unchanged despite court ruling